Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure.

Journal of cellular physiology - 1 Apr 2024

Saravanan Roshni, Balasubramanian Vaishnavi, Sundaram Sandhya, Dev Bhawna, Vittalraj Pavithra, Pitani Ravi Shankar, Shanmugasundaram Gouthaman, Rayala Suresh Kumar, Venkatraman Ganesh

Abstract excerpt

Triple negative breast cancers (TNBC) are an aggressive molecular subtype of breast carcinoma (BC) identified by the lack of receptor expression for estrogen, progesterone, & human epidermal growth factor receptor-2. Lack of tangible drug targets warrants further research in TNBC. LIV1, is a zinc (Zn) transporter known to be overexpressed in few cancer types including BCs. Recently, in the United States of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Carrier Proteins
Share to Cation Transport Proteins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4-Positive T-Lymphocytes

Share to CD8-Positive T-Lymphocytes

Share to Cell Line, Tumor

Share to Lymphocytes, Tumor-Infiltrating

Share to Neoplasm Proteins

Share to Triple Negative Breast Neoplasms

Source

Identifiers

PMID: 38345361
DOI: 10.1002/jcp.31203

Genes

CD4

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Expression of cell surface zinc transporter LIV1 in triple negative breast cancer is an indicator of poor prognosis and therapy failure.PMID 38345361Read ↗

A distinct role in breast cancer for two LIV-1 family zinc transportersSemantic proximity Read ↗

Tumor CTR1 and serum copper dynamics reveal a coordinated copper axis linked to high-grade triple-negative breast cancer biologySemantic proximity Read ↗

Integrated analysis identifies TfR1 as a prognostic biomarker which correlates with immune infiltration in breast cancerSemantic proximity Read ↗

Expression levels of the putative zinc transporter LIV‐1 are associated with a better outcome of breast cancer patientsSemantic proximity Read ↗

LCP1 is a potential prognostic biomarker and correlates with immune infiltration in triple negative breast cancerSemantic proximity Read ↗

Overexpressed VDAC1 in breast cancer as a novel prognostic biomarker and correlates with immune infiltratesSemantic proximity Read ↗

VDAC1 Conversely Correlates with Cytc Expression and Predicts Poor Prognosis in Human Breast Cancer PatientsSemantic proximity Read ↗

CYB561 is a potential therapeutic target for BC and is associated with immune cell infiltrationSemantic proximity Read ↗

Zinc Transporters and the Progression of Breast CancersSemantic proximity Read ↗

LCN2: Versatile players in breast cancerSemantic proximity Read ↗

A zinc metabolism-related gene signature for predicting prognosis and characteristics of breast cancerSemantic proximity Read ↗

ABC transporters in breast cancer: their roles in multidrug resistance and beyondSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.